Over 8 million people living with HIV/AIDS (PLWHA) in sub-Saharan Africa are taking antiretroviral therapy (ART). As HIV-related mortality declines, the population of HIV-infected persons over 50 years is rapidly increasing, and is expected to reach 10 million persons by 2040. The changing epidemic is motivating a public health paradigm shift towards a greater focus on improving long-term health. Data from resource-rich settings describe increased rates of atherosclerosis in HIV-infected versus HIV-uninfected persons. Root causes of the elevated risk arise from a multi-factorial process involving traditional cardiovascular risk factors, altere immune function, toxicity of ART, and the elevated inflammatory state associated with HIV infection. However, similar data on cardiovascular risk factors and outcomes are largely lacking from sub-Saharan Africa, which is home to 70% of HIV-infected persons globally. We will leverage a highly productive and established research infrastructure at a PEPFAR-supported, public HIV clinic in Mbarara, Uganda to enroll PLWHA on ART over 50 years of age, and an age and gender-matched HIV-uninfected comparison group sampled from an NIH- funded, population-based study of social networks in the hospital catchment area.
We aim to measure the prevalence and correlates of atherosclerosis among PLWHA and age and gender-matched HIV- uninfected controls in rural, sub-Saharan Africa. Our outcomes of interest will be: measures of atherosclerosis, including: 1) carotid intima-media thickness, 2) ankle-brachial index, and 3) presence of q-waves on electrocardiogram Our exposures of interest will be: traditional cardiovascular disease risk factors (age, gender, family history of cardiovascular disease, smoking history, diet, activity, body mass index, prevalence of diabetes, and prevalence of hypertension) and HIV-related cardiovascular risk factors (nadir CD4 count, ART duration, gut and plasma microbiome composition, and markers of both immune activation and systemic inflammation). We combine a well-established research infrastructure in a rural, sub-Saharan African setting with world leaders in the study of cardiovascular disease epidemiology in HIV-infected populations. We will leverage these strengths to report atherosclerotic disease burden among PLWHA, as well as state-of- the-art molecular and immunologic testing for HIV-related risk factors. Results from this study will be used to apply for an NIH R01 application for longitudinal study of cardiovascular disease among PLWHA on ART in sub-Saharan Africa. Our over-arching aims include: 1) determination of high-burden health conditions for aging PLWHA on ART in sub-Saharan Africa, 2) identification of modifiable risk factors for prevention and interventions to improve cardiovascular outcomes, and 3) setting priorities for future research.
By 2040, approximately 10 million persons over 50 years old will be infected with HIV in sub-Saharan Africa, accounting for over 25% of the infected population. The HIV care delivery infrastructure developed by the President's Emergency Plan for AIDS Relief in partnership with local governments and non-governmental organizations has created a tremendous opportunity to provide longitudinal comprehensive healthcare for this population. To achieve this goal, and to efficiently allocate limited resources for populations of aging PLWHA on ART, a clear understanding of the health priorities among this population is needed. We will collect epidemiologic data on prevalence and correlates of cardiovascular disease among older HIV-infected persons and HIV-uninfected controls to begin to identify health priorities for this rapidly growing population.
|Okello, Samson; Asiimwe, Stephen B; Kanyesigye, Michael et al. (2016) D-Dimer Levels and Traditional Risk Factors Are Associated With Incident Hypertension Among HIV-Infected Individuals Initiating Antiretroviral Therapy in Uganda. J Acquir Immune Defic Syndr 73:396-402|
|Monaco, Cynthia L; Gootenberg, David B; Zhao, Guoyan et al. (2016) Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome. Cell Host Microbe 19:311-22|
|Siedner, Mark J; Kim, June-Ho; Nakku, Ruth Sentongo et al. (2016) HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda. AIDS 30:667-70|
|Siedner, Mark J; Kim, June-Ho; Nakku, Ruth Sentongo et al. (2016) Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy. J Infect Dis 213:370-8|
|Okello, Samson; Kanyesigye, Michael; Muyindike, Winnie R et al. (2015) Incidence and predictors of hypertension in adults with HIV-initiating antiretroviral therapy in south-western Uganda. J Hypertens 33:2039-45|